Militia Capital Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Militia Capital Partners's MRNA Position: Q4 2025 in Review
Militia Capital Partners increased its Moderna (MRNA) stake by 113% in Q4 2025, buying an estimated $427K and bringing the position to 29,601 shares worth $873K. The position accounts for 0.33% of the portfolio, ranked #98.
Militia Capital Partners first reported a position in MRNA in Q1 2025 and has held it in 4 quarters since. 673 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.
- Militia Capital Partners held 29,601 shares of Moderna worth $873K as of Q4 2025.
- Militia Capital Partners bought 15,717 Moderna shares in Q4 2025, an estimated $427K.
- Moderna made up 0.33% of Militia Capital Partners's portfolio in Q4 2025, its #98 holding.
- Militia Capital Partners first reported a position in Moderna in Q1 2025 and has held it in 4 quarters since.
- 673 funds tracked by Wall St. Rank held Moderna as of Q4 2025.
Based on Militia Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.